Paper · 2025 · Open access
Genetic Variability and Personalized Drug Response: Toward Implementation of Pharmacogenomics in Clinical Practice
Zenodo (CERN European Organization for Nuclear Research) · Published 9 December 2025 · DOI 10.5281/zenodo.17862629
In brief
“Genetic Variability and Personalized Drug Response: Toward Implementation of Pharmacogenomics in Clinical Practice” is a 2025 paper by Fizza Salik1, Fatima Sarwar2*, published in Zenodo (CERN European Organization for Nuclear Research). OpenAlex counts 0 citations as of 21 November 2026. It is open access under a CC BY licence: the full text is free to read at Zenodo (CERN European Organization for Nuclear Research).
- Citations
- 0
- Authors
- 1
Abstract
Interindividual variability in drug response remains a major challenge in clinical pharmacotherapy, contributing to suboptimal efficacy or serious adverse drug reactions. Pharmacogenomics — the study of how genetic variation affects drug response — offers the potential to tailor treatment based on a patient’s unique genetic profile. This article reviews evidence that genetic polymorphisms in drug‑metabolizing enzymes (e.g., cytochrome P450 family), transporters, and drug targets underlie substantial differences in pharmacokinetics and pharmacodynamics across populations. We discuss well-characterized pharmacogenes such as CYP2D6, CYP2C19, and CYP3A4 — their variant alleles and how these influence drug clearance, activation of prodrugs, or risk of toxicity. Advances from candidate-gene studies to genome‑wide and rare‑variant analyses are described. Challenges hindering clinical implementation — including limited evidence for many variants, rare variants’ contribution, polygenic effects, and lack of consensus guidelines — are addressed. We propose methodological strategies for integrating pharmacogenomic testing into clinical workflows and highlight potential benefits for personalized medicine, including improved efficacy, reduced adverse events, and cost‑effective therapy. Finally, we outline future directions, such as incorporating rare variants, using high‑throughput sequencing, and developing robust clinical decision support.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Sarwar2*, F. S. F. (2025). Genetic Variability and Personalized Drug Response: Toward Implementation of Pharmacogenomics in Clinical Practice. Zenodo (CERN European Organization for Nuclear Research). https://doi.org/10.5281/zenodo.17862629
MLA 9
Sarwar2*, Fizza Salik1, Fatima. “Genetic Variability and Personalized Drug Response: Toward Implementation of Pharmacogenomics in Clinical Practice.” Zenodo (CERN European Organization for Nuclear Research), 2025. https://doi.org/10.5281/zenodo.17862629.
Chicago
Sarwar2*, Fizza Salik1, Fatima. 2025. “Genetic Variability and Personalized Drug Response: Toward Implementation of Pharmacogenomics in Clinical Practice.” Zenodo (CERN European Organization for Nuclear Research). https://doi.org/10.5281/zenodo.17862629.
Harvard
Sarwar2*, F. S. F. (2025) ‘Genetic Variability and Personalized Drug Response: Toward Implementation of Pharmacogenomics in Clinical Practice’, Zenodo (CERN European Organization for Nuclear Research). doi:10.5281/zenodo.17862629.
IEEE
F. S. F. Sarwar2*, “Genetic Variability and Personalized Drug Response: Toward Implementation of Pharmacogenomics in Clinical Practice,” Zenodo (CERN European Organization for Nuclear Research), 2025, doi: 10.5281/zenodo.17862629.
BibTeX
@article{sarwar22025genetic,
title = {{Genetic Variability and Personalized Drug Response: Toward Implementation of Pharmacogenomics in Clinical Practice}},
author = {Sarwar2*, Fizza Salik1, Fatima},
journal = {Zenodo (CERN European Organization for Nuclear Research)},
year = {2025},
doi = {10.5281/zenodo.17862629},
url = {https://doi.org/10.5281/zenodo.17862629}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- pharmacogenomics
- interindividual drug response variability
- drug-metabolizing enzymes
- cytochrome P450
- CYP2D6
- CYP2C19
- CYP3A4
- drug transporters
Work with this paper
Most-cited papers in Pharmacology, Toxicology and Pharmaceutics
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingOleg Trott, Arthur J. Olson · Journal of Computational Chemistry · 2009 · 39,860 citations
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityGarrett M. Morris, Ruth Huey, William Lindstrom and 4 more · Journal of Computational Chemistry · 2009 · 26,508 citations
- Development and testing of a general amber force fieldJunmei Wang, Romain M. Wolf, James W. Caldwell and 2 more · Journal of Computational Chemistry · 2004 · 20,080 citations
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1Christopher A. Lipinski, Franco Lombardo, Beryl W. Dominy and 1 more · Advanced Drug Delivery Reviews · 2001 · 19,638 citations
- SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small moleculesAntoine Daina, Olivier Alain Michielin, Vincent Zoete · Scientific Reports · 2017 · 19,557 citations
All highly cited Pharmacology, Toxicology and Pharmaceutics papers
Questions about this paper
How do I cite this paper in APA style?
Sarwar2*, F. S. F. (2025). Genetic Variability and Personalized Drug Response: Toward Implementation of Pharmacogenomics in Clinical Practice. Zenodo (CERN European Organization for Nuclear Research). https://doi.org/10.5281/zenodo.17862629
How many times has this paper been cited?
0 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Zenodo (CERN European Organization for Nuclear Research): sign in and open the full text from this page.
Who wrote this paper?
Fizza Salik1, Fatima Sarwar2*.
What is the DOI of this paper?
10.5281/zenodo.17862629, permanently at https://doi.org/10.5281/zenodo.17862629. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.